Brit Mollenhauer

1999–2025 年に発表

213
論文数
39,594
被引用数
94
h 指数
202
i10 指数

被引用数

Brit Mollenhauer の年別被引用数1986 年: 被引用 1 件1991 年: 被引用 1 件1992 年: 被引用 1 件1994 年: 被引用 2 件1998 年: 被引用 1 件1999 年: 被引用 1 件2000 年: 被引用 3 件2001 年: 被引用 7 件2002 年: 被引用 7 件2003 年: 被引用 13 件2004 年: 被引用 14 件2005 年: 被引用 11 件2006 年: 被引用 31 件2007 年: 被引用 24 件2008 年: 被引用 47 件2009 年: 被引用 53 件2010 年: 被引用 53 件2011 年: 被引用 91 件2012 年: 被引用 118 件2013 年: 被引用 180 件2014 年: 被引用 222 件2015 年: 被引用 224 件2016 年: 被引用 217 件2017 年: 被引用 342 件2018 年: 被引用 398 件2019 年: 被引用 1,389 件2020 年: 被引用 1,843 件2021 年: 被引用 2,435 件2022 年: 被引用 2,164 件2023 年: 被引用 1,808 件2024 年: 被引用 2,962 件2025 年: 被引用 1,685 件2026 年: 被引用 72 件1987〜1990 年は被引用が無いため表示していません1993 年は被引用が無いため表示していません1995〜1997 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,033 件、この内訳の 19.4%イギリス: 引用元論文 1,907 件、この内訳の 9.1%中国: 引用元論文 1,658 件、この内訳の 8%ドイツ: 引用元論文 1,542 件、この内訳の 7.4%イタリア: 引用元論文 1,379 件、この内訳の 6.6%カナダ: 引用元論文 821 件、この内訳の 3.9%スペイン: 引用元論文 762 件、この内訳の 3.6%フランス: 引用元論文 661 件、この内訳の 3.2%スウェーデン: 引用元論文 657 件、この内訳の 3.1%オランダ: 引用元論文 641 件、この内訳の 3.1%オーストラリア: 引用元論文 555 件、この内訳の 2.7%日本: 引用元論文 537 件、この内訳の 2.6%
0%19.4%その他 27.3%

分野

  • Medicine68.4%
  • Biochemistry, Genetics and Molecular Biology15.1%
  • Neuroscience10.3%
  • Computer Science1.5%
  • Health Professions0.9%
  • Immunology and Microbiology0.8%
  • その他3%

トピック

  • Parkinson's Disease Mechanisms and Treatments15.8%
  • Neurological disorders and treatments6.6%
  • Alzheimer's disease research and treatments6.1%
  • Dementia and Cognitive Impairment Research5.1%
  • Neuroinflammation and Neurodegeneration Mechanisms1.8%
  • SARS-CoV-2 and COVID-19 Research1.6%
  • その他63%

共著者

全論文

検索で開く
  1. Diagnosis and management of dementia with Lewy bodies

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Álex Iranzo, Kejal Kantarci, Daniel Kaufer, Walter A. Kukull, Virginia M.‐Y. Lee, James B. Leverenz, Simon J.G. Lewis, Carol F. Lippa, Angela Lunde, Mario Masellis, Eliezer Masliah, Pamela J. McLean, Brit Mollenhauer, Thomas J. Montine, Emilio Moreno, Etsuro Mori, Melissa E. Murray, John T. O’Brien, Sotoshi Orimo, Ronald B. Postuma, Shankar Ramaswamy, Owen A. Ross, David P. Salmon, Andrew Singleton, Angela Taylor, Alan Thomas, Pietro Tiraboschi, Jon B. Toledo, John Q. Trojanowski, Debby W. Tsuang, Zuzana Walker, Masahito Yamada, Kenji Kosaka - Neurology 2017 被引用: 4,446

  2. The Parkinson Progression Marker Initiative (PPMI)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Keith A. Hawkins, Jamie L. Eberling, Deborah W. Brooks, David Russell, Laura Leary, Stewart A. Factor, Barbara Sommerfeld, Penelope Hogarth, Emily Pighetti, Karen Williams, David G. Standaert, Stephanie Guthrie, Robert A. Hauser, Holly Delgado, Joseph Jankovic, Christine Hunter, Matthew Stern, Baochan Tran, Jim Leverenz, Marne Baca, Sam Frank, Cathi-Ann Thomas, Irene Hegeman Richard, Cheryl Deeley, Linda Rees, Fabienne Sprenger, Elisabeth Lang, Holly A. Shill, Sanja Obradov, Hubert Fernandez, Adrienna Winters, Daniela Berg, Katharina Gauss, Douglas Galasko, Deborah Fontaine, Zoltán Mari, Melissa Gerstenhaber, David J. Brooks, Sophie Malloy, Paolo Barone, Katia Longo, Tom Comery, Bernard Ravina, Igor D. Grachev, Kim P. Gallagher, Michelle Collins, Katherine L. Widnell, Suzanne Ostrowizki, Paulo Fontoura, Tony W. Ho, Johan Luthman, Marcel van der Brug, Alastair D. Reith, Peggy Taylor - Progress in Neurobiology 2011 被引用: 1,915

  3. Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Neurology 2023 被引用: 693

  4. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jan Kassubek, Florian Krismer, Johannes Levin, Stefan Lorenzl, Huw R. Morris, Peter J. Nestor, Wolfgang H. Oertel, Werner Poewe, Gil D. Rabinovici, James B. Rowe, Gerard D. Schellenberg, Klaus Seppi, Thilo van Eimeren, Gregor K. Wenning, Adam L. Boxer, Lawrence I. Golbe, Irene Litvan, for the Movement Disorder Society–endorsed PSP Study Group - Movement Disorders 2017 被引用: 2,332

  5. A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Daniel Weintraub, Yuge Xiao, Andrew Siderowf, Billy Dunn, Kenneth Marek - The Lancet Neurology 2024 被引用: 563

  6. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

    著者: , , , , , , , , , , , , , , , - Movement Disorders 2012 被引用: 2,531

  7. Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Annette Janzen, Smandra Leu-Semenescu, Giuseppe Plazzi, Flavio Nobili, F. Sixel-Doering, Petr Dušek, Frédérik Bes, Pietro Cortelli, Kaylena A. Ehgoetz Martens, Jean‐François Gagnon, Carles Gaig, Marco Zucconi, Claudia Trenkwalder, Ziv Gan‐Or, Christine Lo, Michal Rolinski, Philipp Mahlknecht, Evi Holzknecht, Angel R Boeve, Luke Teigen, Gianpaolo Toscano, Geert Mayer, Silvia Morbelli, Benjamin Dawson, Amélie Pelletier - Brain 2019 被引用: 1,097

  8. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Science 2020 被引用: 2,041

  9. The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of Clinical and Translational Neurology 2018 被引用: 686

  10. Trial of Prasinezumab in Early-Stage Parkinson’s Disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hanno Svoboda, Markus Britschgi, Florian Lipsmeier, Ekaterina Volkova-Volkmar, Michael Lindemann, Sebastian Dziadek, Štefan Holiga, Daria Rukina, Thomas Kustermann, Geoffrey A. Kerchner, Paulo Fontoura, Daniel Umbricht, Rachelle S. Doody, Tania Nikolcheva, Azad Bonni - New England Journal of Medicine 2022 被引用: 395

  11. CSF and blood biomarkers for Parkinson's disease

    著者: , , , , , , , , - The Lancet Neurology 2019 被引用: 671

  12. Trial of Cinpanemab in Early Parkinson’s Disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2022 被引用: 333

  13. Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid

    著者: , , , , , , , - JAMA Neurology 2016 被引用: 507

  14. Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies

    著者: , , , , , , , , , , , , , , , , , , , , - Brain 2021 被引用: 190

  15. The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder

    著者: , , , , , , , , , - Movement Disorders 2017 被引用: 564

  16. Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and Safinamide

    著者: , , - Movement Disorders Clinical Practice 2020 被引用: 338

  17. Accurate Detection of α‐Synuclein Seeds in Cerebrospinal Fluid from Isolated Rapid Eye Movement Sleep Behavior Disorder and Patients with Parkinson's Disease in the DeNovo Parkinson (DeNoPa) Cohort

    著者: , , , , , , , , , , , , , , - Movement Disorders 2023 被引用: 113

  18. Parkinson’s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas Gasser, Piotr Gawron, Lars Geffers, Virginie Giarmana, Enrico Glaab, Clarissa P. C. Gomes, Nikolai Goncharenko, Jérôme Graas, Mariela Graziano, Valentin Grouès, Anne Grünewald, Wei Gu, Gaël Hammot, Anne-Ma rie Hanff, Linda Hansen, Maxime Hansen, Hulda S. Haraldsdóttir, Laurent Heirendt, Sylvia Herbrink, Sascha Herzinger, Michaël Heymann, Karsten Hiller, Géraldine Hipp, Michele Hu, Laëtitia Huiart, Alexander Hundt, Nadine Jacoby, Jacek Jarosław, Yohan Jaroz, Pierre Kolber, Joachim Kutzera, Zied Landoulsi, Catherine Larue, Roseline Lentz, Inga Liepelt, Robert Liszka, Laura Longhino, Victoria Lorentz, Clare E. Mackay, Walter Maetzler, Katrin Marcus, Guilherme Fernandes Marques, Jan Martens, Conny Mathay, Piotr Matyjaszczyk, Patrick May, Françoise Meisch, Myriam Menster, Maura Minelli, Michel Mittelbronn, Brit Mollenhauer, Kathleen Mommaerts, Carlos S. Moreno, Friedrich Mühlschlegel, Romain Nati, Ulf Nehrbass, Sarah Nickels, Béatrice Nicolai, Jean-Paul Nicolay, Alberto Noronha, Wolfgang H. Oertel, Marek Ostaszewski, Sinthuja Pachchek, Claire Pauly, Magali Perquin, Dorothea Reiter, Isabel Rosety, Kirsten Rump, Venkata Satagopam, Marc Schlesser ほか 14 名 - BMC Biology 2020 被引用: 223

  19. Progression of clinical markers in prodromal Parkinson’s disease and dementia with Lewy bodies: a multicentre study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Han‐Joon Kim, Frédérik Bes, Birgit Högl, Karel Šonka, Giuseppe Fiamingo, Pietro Mattioli, Maria L. Lavadia, Jessika Suescun, Kyung Ah Woo, Sara Marelli, Kaylena A. Ehgoetz Martens, Annette Janzen, Giuseppe Plazzi, Brit Mollenhauer, Mariana Fernandes, Yuanyuan Li, Pietro Cortelli, Michela Figorilli, Calogero Edoardo Cicero, Carolin Schaefer, Lily Guiraud, Giuseppe Lanza, Jean‐François Gagnon, Jun‐Sang Sunwoo, Abubaker Ibrahim, Nicola Girtler, Claudia Trenkwalder, Luca Baldelli, Amélie Pelletier, Ronald B. Postuma, for the International REM Sleep Behavior Disorder Study Group - Brain 2023 被引用: 124

  20. Reliability and validity of the Roche PD Mobile Application for remote monitoring of early Parkinson’s disease

    著者: , , , , , , , , , , , , , , , , - Scientific Reports 2022 被引用: 111

  21. A Mutation in VPS35, Encoding a Subunit of the Retromer Complex, Causes Late-Onset Parkinson Disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gerhard Ransmayr, Juliane Winkelmann, Thomas Meitinger, Tim M. Strom - The American Journal of Human Genetics 2011 被引用: 902

  22. Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson’s disease and dementia with Lewy bodies

    著者: , , , , , , , - Brain 2015 被引用: 418

  23. Autophagy inhibition promotes SNCA/alpha-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotype

    著者: , , , , , , , , , , , , , , , , , , , , - Autophagy 2017 被引用: 266

  24. A Statement of the MDS on Biological Definition, Staging, and Classification of Parkinson's Disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Movement Disorders 2023 被引用: 82